RBRM DD, 4 million dollar year! Growing at 100%

[johnnyfive]

OTO: RBRM

Established Medical Treatments
Company Publicly Trading as RBRM
ReBuilder Medical Technologies, Inc. (OTO: RBRM),
manufactures patent-pending devices and treatment
systems for Neuropathy, Molluscum Contagiosum and
Diabetes. The company has been successfully
manufacturing and distributing medical devices for five
years via the internet.

Current product lines include:

· The ReBuilder --a hand held,
electronic, FDA approved medical
device for the treatment of
Neuropathy.

· The Phillips Molluscum Treatment
System for Molluscum Contagiosum
-- a complete line of treatment
products designed to address and
heal Molluscum Contagiosum, a
contagious skin infection.
(www.molluscum.com)

· Diabetic Personal Hygiene
products -- a complete line of
products for people who suffer from
diabetes. Soon to be released, this
line utilizes RBRM's proprietary
silver based technology.

· Devices -- an electronic allergy detection system
and a pocket sized instrument for blood samples.
www.rebuildermedical.com

Fast Facts About The Rebuilder®

· Over 30,000 patients have already been treated using
the cutting-edge technology of the ReBuilder. This
ingenious product has a success rate that exceeds 90%
because it treats the cause as well as the symptom.

· Seven percent of the U.S. population suffers
from diabetes -- 20,800,000
children and adults.

· Thirty percent of those diagnosed
with diabetes will eventually suffer
from peripheral neuropathy, pain
and numbness in the feet and
hands that can lead to complete
loss of mobility, gangrene, and
eventual amputations.

· The current cost of treating
diabetes is $132B per year or
one out of every 10 health care
dollars spent.

· Neuropathy sufferers constitute
33% of this market or
$43.56B in revenue.

· The ReBuilder's only competition
is from prescription drug therapy.
Studies show that drug therapy is far less successful
because it is prone to side-effects and addiction.

· ReBuilder Medical Technologies has targeted
10% of this market, or $435M
in its next two market years,
and is on course to meet this goal.

[Blash]

Glad to see that you've finally given up the incessant hyping of WHKA.....
Your last post on that POS was: "WHKA on fire breakout $0.011!"
Now at $0.0025.......
Jeez.....was that a joke!!!

WHERE DO YOU FIND THESE DOGS???